Chief Investigator Responsibilities for CTIMPs (R3)
Chief Investigator (CI) Responsibilities for CTIMPs. Updated for the latest GCP (ICH-GCP E6 (R3)) and UK Clinical Trials Regulations.
We've received your request and look forward to sharing news about King's Health Partners Clinical Trials Office with you soon. For our latest updates, you can also follow us on LinkedIn.
If you'd like to get in touch with the team you can contact us.
All courses are being updated inline with GCP (ICH-GCP E6 (R3)) and UK Clinical Trials Regulations. Courses restart in February 2026.
All Chief Investigators and staff currently working on CTIMPs must complete ICH-GCP E6 (R3) focussed training by 28 April 2026.
Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025, also know as ICH-GCP R3, is due to be fully implemented on 28 April 2026. Read our statement about updates to training.
Chief Investigator (CI) Responsibilities for CTIMPs. Updated for the latest GCP (ICH-GCP E6 (R3)) and UK Clinical Trials Regulations.
GCP Refresher for CTIMPs: Updated for the latest GCP (ICH-GCP E6 (R3)) and UK Clinical Trials Regulations.
If you have questions or complaints about how your Personal Data is used, contact khpcto.crateam@kcl.ac.uk or your organisation’s Data Protection Officer:
King’s College London
Guys and St Thomas’
King’s College Hospital
South London and Maudsley.